| GC35619-100mg |
|
1567335-29-8 |
|
0 |
C25H29ClN2O2 |
|
|
|
| GC35619-50mg |
|
1567335-29-8 |
|
0 |
C25H29ClN2O2 |
|
|
|
| GC35619-10mg |
|
1567335-29-8 |
|
0 |
C25H29ClN2O2 |
|
|
|
| GC35619-5mg |
|
1567335-29-8 |
|
0 |
C25H29ClN2O2 |
|
|
|
| GC35619-10mM (in 1mL DMSO) |
|
1567335-29-8 |
|
0 |
C25H29ClN2O2 |
|
|
|
| GC35618-5mg |
|
60451-47-0 |
|
0 |
C59H96O27 |
|
|
|
| GC35617-10mg |
|
12672-45-6 |
|
0 |
C56H92O22 |
|
|
|
| GC35617-5mg |
|
12672-45-6 |
|
0 |
C56H92O22 |
|
|
|
| GC35616-5mg |
|
20853-58-1 |
|
0 |
C41H66O13 |
|
|
|
| GC35613-500mg |
|
610309-89-2 |
Carvedilol phosphate hemihydrate
|
0 |
C24H26N2O4 . H3PO4 .1/2H2O |
|
|
|
| GC35613-100mg |
|
610309-89-2 |
Carvedilol phosphate hemihydrate
|
0 |
C24H26N2O4 . H3PO4 .1/2H2O |
|
|
|
| GC35610-100mg |
|
1083076-69-0 |
Cariprazine hydrochloride
|
0 |
C21H33Cl3N4O |
|
|
|
| GC35610-50mg |
|
1083076-69-0 |
Cariprazine hydrochloride
|
0 |
C21H33Cl3N4O |
|
|
|
| GC35610-10mg |
|
1083076-69-0 |
Cariprazine hydrochloride
|
0 |
C21H33Cl3N4O |
|
|
|
| GC35610-5mg |
|
1083076-69-0 |
Cariprazine hydrochloride
|
0 |
C21H33Cl3N4O |
|
|
|
| GC35610-2mg |
|
1083076-69-0 |
Cariprazine hydrochloride
|
0 |
C21H33Cl3N4O |
|
|
|
| GC35610-10mM (in 1mL DMSO) |
|
1083076-69-0 |
Cariprazine hydrochloride
|
0 |
C21H33Cl3N4O |
|
|
|
| GC35609-5mg |
|
115722-23-1 |
Cardiotoxin Analog (CTX) IV 6-12
|
0 |
C48H70N10O7 |
|
|
|
| GC35609-1mg |
|
115722-23-1 |
Cardiotoxin Analog (CTX) IV 6-12
|
0 |
C48H70N10O7 |
|
|
|
| GC35608-100mg |
|
192203-60-4 |
Carboxypeptidase G2 (CPG2) Inhibitor
|
0 |
C13H15NO6S |
|
|
|
